FULL VET CRO

OCR is specialized in the design of clinical studies of pets with naturally occurring pathologies
for efficacy assessment of drug candidates and medical devices for Human Health.
OCR is moving its premises to the IRCL (Lille Institute for Cancer Research), near the University Hospital.
Although OCR has largely expanded its activities to clinical research for veterinary health in various therapeutic areas, the company remains aligned with its values of “One Health”.
The installation of OCR within the IRCL is a logical continuation of OCR’s commitment and investments in cancer research projects within various academic-private consortia, including the OncoLille consortium and the joint PRISM-OCR research laboratory.
In a daily dynamic, this rapprochement perpetuates the fruitful exchanges between the different partners of human and veterinary medicine, and consolidates the conviction at the origin of which the OCR company was born.
Between 25-27,of May OCR, represented by our Head of R&D Agata Rybicka, had participated in annual congress of European Society of Veterinary Oncology (ESVONC) in Alicante, Spain.
Morning sessions included discussions on the link between nutrition and cancer, the application of liquid biopsy in veterinary clinics and selected surgical procedures, while the afternoons were devoted to general presentations and abstract presentations by residents. It was also an opportunity for OCR to meet investigators participating in our clinical studies across Europe (Dr Jagielski and Dr Hildebrand pictured).
The OCR team is gradually expanding, including outside France. For the past few months, we have been working with our new local clinical research associate in Poland, Dr Karolina Ziomek.
Karolina completed her studies of veterinary medicine in Poland and her course in clinical trial monitoring and coordination.
She loves old, overweight Labradors, which she constantly adopts to help them lose weight. She currently owns Beza, Ora, Lena and a cat named Plamka.